The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G 1 cyclins/cyclin‐dependent kinases and the phosphoinositide 3‐kinase/AKT signaling cascade
Open accessAbstract
Increasing evidence suggests that PRMT 5, a protein arginine methyltransferase, is involved in tumorigenesis. However, no systematic research has demonstrated the cell‐transforming activity of PRMT 5. We investigated the involvement of PRMT 5 in tumor formation. First, we showed that PRMT 5 was associated with many human cancers, through statistical analysis of microarray data in the NCBI GEO database. Overexpression of ectopic PRMT 5 per se or its specific sh RNA enhanced or reduced cell growth under conditions of normal or low concentrations of serum, low cell density, and poor cell attachment. A stable clone that expressed exogenous PRMT 5 formed tumors in nude mice, which demonstrated that PRMT 5 is a potential oncoprotein.PRMT 5 accelerated cell cycle progression through G 1 phase and modulated regulators of G 1; for example, it upregulated cyclin‐dependent kinase (CDK) 4,CDK 6, and cyclins D 1,D 2 and E 1, and inactivated retinoblastoma protein (R b). Moreover,PRMT 5 activated phosphoinositide 3‐kinase (PI 3K)/AKT and suppressed c‐J un N‐terminal kinase (JNK)/c‐J un signaling cascades. However, only inhibition of PI 3 K activity, and not overexpression of JNK, blocked PRMT 5‐induced cell proliferation. Further analysis of PRMT 5 expression in 64 samples of human lung cancer tissues by microarray and western blot analysis revealed a tight association of PRMT 5 with lung cancer. Knockdown of PRMT 5 retarded cell growth of lung cancer cell lines A 549 and H 1299. In conclusion, to the best of our knowledge, we have characterized the cell‐transforming activity of PRMT 5 and delineated its underlying mechanisms for the first time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pollack, B. P., Kotenko, S. V., He, W., Izotova, L. S., Barnoski, B. L., & Pestka, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31531 · Cited by 290
Cited by
Protein arginine methyltransferases and cancer
Yang, Y., & Bedford, M. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3409 · Cited by 1,083
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Chan-Penebre, E., Kuplast, K. G., Majer, C. R., Boriack-Sjodin, P. A., Wigle, T. J., Johnston, L. D., Rioux, N., Munchhof, M. J., Jin, L., Jacques, S. L., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1810 · Cited by 569
The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond
Stopa, N., Krebs, J. E., & Shechter, D. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1847-9 · Cited by 513
Inhibitors of Protein Methyltransferases and Demethylases
Kaniskan, H. Ü., Martini, M. L., & Jin, J. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00801 · Cited by 297
Protein arginine methyltransferases: promising targets for cancer therapy
Hwang, J. W., Cho, Y., Bae, G.-U., Kim, S.-N., & Kim, Y. K. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00613-y · Cited by 268
Metadata
- Authors
- Wei, T. W., Juan, C., Hisa, J., Su, L., Lee, Y. G., Chou, H., Chen, J. M., Wu, Y., Chiu, S., Hsu, C., Liu, K., & Yu, C. R.
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2012-08-08
- Volume
- 103
- Issue
- 9
- Pages
- 1640-1650
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- OpenAlex
- W2036400107
- Cited by
- 189
- References
- 1
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G 1 cyclins/cyclin‐dependent kinases and the phosphoinositide 3‐kinase/AKT signaling cascade. https://app.cochat.ai/papers/10.1111/j.1349-7006.2012.02367.x
- The paper
- Wei, T. W., Juan, C., Hisa, J., Su, L., Lee, Y. G., Chou, H., Chen, J. M., Wu, Y., Chiu, S., Hsu, C., Liu, K., & Yu, C. R. (2012). Protein arginine methyltransferase 5 is a potential oncoprotein that upregulates G 1 cyclins/cyclin‐dependent kinases and the phosphoinositide 3‐kinase/AKT signaling cascade. Cancer Science. https://doi.org/10.1111/j.1349-7006.2012.02367.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.